Sleep Apnea Withdrawn Phase Trials for Acetazolamide (DB00819)

Also known as: Sleep apnoeas / Sleep Apnoea / Sleep Apnea Syndrome / Apnea, Sleep / Sleep Apnea Syndromes / Sleep apnoea syndromes / Sleep apnoea syndrome / Apnea syndrome / Apnoea syndrome

IndicationStatusPhase
DBCOND0030087 (Sleep Apnea)WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02670096A Single-center Pilot Study Evaluating the Immediate Effects of Low-dose Acetazolamide on Respiratory Control in Subjects With Treatment Emergent Sleep Disordered BreathingTreatment